T. Uchida

发表

Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstatin, produced by MH435-hF3.

M. Imoto, T. Takeuchi, K. Isshiki, 1986, The Journal of antibiotics.

Screening, Purification and Properties of a Specific Antiphage Substance, AFS, against Filamentous Phage of Escherichia coli

K. Arima, T. Beppu, T. Uchida, 1975 .

Immunostimulatory and antitumor activities of monoglycosylceramides having various sugar moieties.

M. Morita, K. Akimoto, Y. Koezuka, 1995, Biological & pharmaceutical bulletin.

Antitumor activities of combined treatment with a novel immunomodulator, (2S,3S,4R)-1-O-(alpha-D-Galactopyranosyl)-2-(N-Hexacosanoylamino)-1,3,4 - octadecanetriol (KRN7000), and radiotherapy in tumor-bearing mice.

Y. Koezuka, T. Uchida, H. Fukushima, 1996, Oncology research.

Antitumor activities of α-, β-monogalactosylceramides and four diastereomers of an α-galactosylceramide

Y. Koezuka, T. Uchida, H. Fukushima, 1995 .

Dioxamycin, a new benz[a]anthraquinone antibiotic.

H. Naganawa, T. Takeuchi, T. Sawa, 1991, The Journal of antibiotics.

Enhancing effects of α-, β-monoglycosylceramides on natural killer cell activity

Y. Koezuka, T. Uchida, Y. Yamaguchi, 1996 .

KRN7000, a novel immunomodulator, and its antitumor activities.

Y. Koezuka, T. Uchida, H. Fukushima, 1995, Oncology research.

Structure-antitumor activity relationship of semi-synthetic spicamycin analogues.

T. Tsuruo, Y. Hayakawa, H. Seto, 1993, The Journal of antibiotics.

Structure-antitumor activity relationship of semi-synthetic Spicamycin derivatives.

T. Tsuruo, N. Ōtake, T. Uchida, 1995, The Journal of antibiotics.

Radioprotective effects of α-galactosylceramides

M. Morita, K. Akimoto, Y. Koezuka, 1995 .

Saquayamycins, new aquayamycin-group antibiotics.

M. Imoto, H. Naganawa, T. Takeuchi, 1985, The Journal of antibiotics.

New antitumor antibiotics, ditrisarubicins A, B and C.

M. Imoto, H. Naganawa, T. Takeuchi, 1983, The Journal of antibiotics.

New anthracycline antibiotics: serirubicin and 1-hydroxyserirubicin.

M. Imoto, H. Naganawa, T. Takeuchi, 1985, Journal of antibiotics (Tokyo. 1968).

Strong binding of ditrisarubicin B to DNA.

Y. Takahashi, T. Takeuchi, H. Umezawa, 1988, The Journal of antibiotics.

ANTHRAQUINONE ANTIBIOTIC

H. Naganawa, T. Takeuchi, T. Sawa, 2006 .

Effect of α-Galactosylceramides on Bone Marrow Cells in Vitro and Hematopoiesis in Vivo

M. Morita, Y. Koezuka, T. Uchida, 1996 .

Effects of alpha-galactosylceramides on bone marrow cells in vitro and hematopoiesis in vivo.

M. Morita, Y. Koezuka, T. Uchida, 1996, Biological & pharmaceutical bulletin.

Inhibitory effect of a spicamycin derivative, KRN5500, on the growth of hepatic metastasis of human colon cancer-producing tissue polypeptide antigen

T. Tsuruo, N. Ōtake, T. Uchida, 1996, Cancer Chemotherapy and Pharmacology.

Antitumor activity of SPM VIII, a derivative of the nucleoside antibiotic spicamycin, against human tumor xenografts.

T. Tsuruo, Y. Hayakawa, H. Seto, 1994, The Journal of antibiotics.

Antitumor activity of a spicamycin derivative, KRN5500, and its active metabolite in tumor cells.

T. Tsuruo, H. Yamaki, T. Uchida, 1994, Oncology research.

Immunosuppressive activity of serum from liver-grafted rats: in vitro specific inhibition of mixed lymphocyte reactivity by antibodies against class II RT1 alloantigens.

T. Uchida, N. Kamada, M. Tsurufuji, 1987, Immunology.